Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Abstract Background Before the targeted therapies era, cytotoxic chemotherapy (CCT) was an option for advanced hepatocellular carcinoma (HCC), even with the lack of supporting evidence. Since the last decade, sorafenib has been established as the first-line therapy. Although new agents are being inc...

Full description

Bibliographic Details
Main Authors: Leonardo Gomes da Fonseca, Guilherme Nader Marta, Maria Ignez Freitas Melro Braghiroli, Aline Lopes Chagas, Flair Jose Carrilho, Paulo Marcelo Hoff, Jorge Sabbaga
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Sorafenib
Cytotoxic chemotherapy
Survival rate
Online Access:http://link.springer.com/article/10.1186/s12885-018-5173-0

Internet

http://link.springer.com/article/10.1186/s12885-018-5173-0

Similar Items